Gf Fund Management Co., Ltd. - CSI Hong Kong Brand Name Drug Index ETF (SHA:513120)
1.281
+0.009 (0.71%)
At close: Apr 14, 2026
SHA:513120 Holdings Information
SHA:513120 is an equity ETF with a total of 40 individual holdings. The top holdings are BeOne Medicines AG stock at 9.97%, Innovent Biologics at 9.61%, Akeso at 8.40%, WuXi Biologics at 8.22%, and Sino Biopharmaceutical at 7.04%.
Total Holdings
40
Top 10 Percentage
69.92%
Asset Class
Equity
ETF Category
Health Care
Assets
n/a
PE Ratio
24.57
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | HKG: 6160 | BeOne Medicines AG | 9.97% |
| 2 | HKG: 1801 | Innovent Biologics, Inc. | 9.61% |
| 3 | HKG: 9926 | Akeso, Inc. | 8.40% |
| 4 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 8.22% |
| 5 | HKG: 1177 | Sino Biopharmaceutical Limited | 7.04% |
| 6 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 6.87% |
| 7 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 6.55% |
| 8 | HKG: 2359 | WuXi AppTec Co., Ltd. | 5.09% |
| 9 | HKG: 1530 | 3SBio Inc. | 4.94% |
| 10 | HKG: 2228 | XtalPi Holdings Limited | 3.23% |
| 11 | HKG: 2268 | WuXi XDC Cayman Inc. | 3.02% |
| 12 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2.62% |
| 13 | n/a | Cash | 2.03% |
| 14 | HKG: 0867 | China Medical System Holdings Limited | 1.89% |
| 15 | HKG: 1548 | Genscript Biotech Corporation | 1.89% |
| 16 | INCPF | InnoCare Pharma Ltd | 1.85% |
| 17 | HKG: 6855 | Ascentage Pharma Group International | 1.55% |
| 18 | HKG: 9688 | Zai Lab Limited | 1.54% |
| 19 | HKG: 9995 | RemeGen Co., Ltd. | 1.51% |
| 20 | HKG: 0013 | HUTCHMED (China) Limited | 1.26% |
| 21 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H | 1.24% |
| 22 | HKG: 2162 | Keymed Biosciences Inc. | 1.24% |
| 23 | HKG: 2096 | Simcere Pharmaceutical Group Limited | 1.20% |
| 24 | HKG: 0512 | Grand Pharmaceutical Group Limited | 1.13% |
| 25 | HKG: 2196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1.07% |
As of Dec 31, 2025